1

Mini-antibodies Reactivate the p53 protein: A Potential Pathway for Malignant Management

News Discuss 
A significant breakthrough in cancer study is occurring with the use of nanobodies to restore mutated p53. This crucial malignant inhibitor protein is frequently disabled in several kinds of tumors, causing https://socialfactories.com/story7530804/nanobodies-restore-tumor-suppressor-p53-the-new-hope-for-cancer-treatment

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story